Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative

Journal of the National Cancer Institute
Jennifer L Caswell-JinAllison W Kurian

Abstract

In cascade testing, genetic testing for an identified familial pathogenic variant extends to disease-free relatives to allow genetically targeted disease prevention. We evaluated the results of an online initiative in which carriers of 1 of 30 cancer-associated genes, or their first-degree relatives, could offer low-cost testing to at-risk first-degree relatives. In the first year, 1101 applicants invited 2280 first-degree relatives to undergo genetic testing. Of invited relatives, 47.5% (95% confidence interval [CI] = 45.5 to 49.6%) underwent genetic testing, and 12.0% (95% CI = 9.2 to 14.8%) who tested positive continued the cascade by inviting additional relatives to test. Of tested relatives, 4.9% (95% CI = 3.8 to 6.1%) had a pathogenic variant in a different gene from the known familial one, and 16.8% (95% CI = 14.7 to 18.8%) had a variant of uncertain significance. These results suggest that an online, low-cost program is an effective approach to implementing cascade testing, and that up to 5% of the general population may carry a pathogenic variant in 1 of 30 cancer-associated genes.

Associated Clinical Trials

Aug 31, 2020·Katherine Nathanson, MD

Citations

Mar 7, 2019·Journal of the National Cancer Institute·Beth N PeshkinMarc D Schwartz
Mar 4, 2020·Personalized Medicine·Margaret WaltzR Jean Cadigan
Dec 21, 2019·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Erica M BednarSally W Vernon
Apr 28, 2020·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Samantha PollardDean A Regier
Jan 11, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melissa K FreySteven Lipkin
Jan 11, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kenneth OffitSemanti Mukherjee
Feb 26, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W Kurian, Steven J Katz
Sep 25, 2019·Cold Spring Harbor Perspectives in Medicine·Jaclyn Schienda, Jill Stopfer
Sep 19, 2019·NPJ Genomic Medicine·Eliza CourtneyJoanne Ngeow
Sep 26, 2020·Nature Reviews. Clinical Oncology·Ophira GinsburgPaul Brennan
Feb 14, 2019·Database : the Journal of Biological Databases and Curation·Ryan BarrettJeremy Ginsberg
May 18, 2019·American Society of Clinical Oncology Educational Book·Stephanie A CohenBanu K Arun
Aug 14, 2019·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Beth N PeshkinMarc D Schwartz
Jan 19, 2021·Patient Education and Counseling·Marleah DeanDeborah Cragun
Apr 2, 2021·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Lora J H BeanUNKNOWN ACMG Board of Directors
Apr 16, 2021·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Pedro L S UsonNiloy Jewel Samadder
May 28, 2021·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Ezimamaka AjufoDaniel J Rader

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.